Gemini Therapeutics Inc. (NASDAQ: GMTX) stock jumped 28.85% on Friday to $2.01 against a previous-day closing price of $1.56. With 1.42 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.15 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.0300 whereas the lowest price it dropped to was $1.2500. The 52-week range on GMTX shows that it touched its highest point at $5.48 and its lowest point at $1.16 during that stretch. It currently has a 1-year price target of $1.88.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GMTX was up-trending over the past week, with a rise of 25.63%, but this was up by 28.85% over a month. Three-month performance surged to 27.22% while six-month performance rose 14.20%. The stock lost -50.00% in the past year, while it has lost -30.93% so far this year. A look at the trailing 12-month EPS for GMTX yields -1.58 with Next year EPS estimates of -0.48. For the next quarter, that number is -0.14. This implies an EPS growth rate of 66.30% for this year and 20.00% for next year.
Float and Shares Shorts:
At present, 43.21 million GMTX shares are outstanding with a float of 38.26 million shares on hand for trading. On Jul 14, 2022, short shares totaled 1.43 million, which was 3.32% higher than short shares on Jun 14, 2022. In addition to Dr. Georges Gemayel C.F.A., Ph.D. as the firm’s Interim Pres & CEO and Exec. Chairperson, Mr. Brian Piekos serves as its Chief Bus. Officer, CFO, Principal Accounting & Principal Financial Officer.
Through their ownership of 77.99% of GMTX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 4.46% of GMTX, in contrast to 36.99% held by mutual funds. Shares owned by individuals account for 32.92%. As the largest shareholder in GMTX with 11.57% of the stake, BML Capital Management LLC holds 5,000,000 shares worth 5,000,000. A second-largest stockholder of GMTX, Suvretta Capital Management LLC, holds 2,372,267 shares, controlling over 5.49% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in GMTX, holding 1,176,913 shares or 2.72% stake. With a 0.96% stake in GMTX, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 413,417 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.55% of GMTX stock, is the second-largest Mutual Fund holder. It holds 237,759 shares valued at 0.4 million. Fidelity Extended Market Index Fu holds 0.36% of the stake in GMTX, owning 156,348 shares worth 0.26 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2022, GMTX reported revenue of $0.00 and operating income of -$15.18M. Over the past year, revenue came in at $0.00 while operating income stood at -$67.69M. It generated -$15.23M net income for the quarter, which came to -$68.05M over the last twelve months. The EBITDA in the recently reported quarter was -$15.16M and diluted EPS was -$0.35. EBITDA for the full year was -$67.51M.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GMTX since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With GMTX analysts setting a high price target of $2.00 and a low target of $2.00, the average target price over the next 12 months is $2.00. Based on these targets, GMTX could drop -0.5% to reach the target high and fall by -0.5% to reach the target low. Reaching the average price target will result in a decline of -0.5% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. GMTX will report FY 2022 earnings on 03/27/2023. Analysts have provided yearly estimates in a range of -$0.70 being high and -$0.70 being low. For GMTX, this leads to a yearly average estimate of -$0.70. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. The surprise factor in the prior quarter was $0.09. Based on analyst estimates, the high estimate for the next quarter is -$0.09 and the low estimate is -$0.09. The average estimate for the next quarter is thus -$0.09.